Volume 6; Issue 3

Main
HIV Medicine
Volume 6; Issue 3

HIV Medicine

Volume 6; Issue 3

1

Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients

E Seminari, A Castagna, A Soldarini, L Galli, G Fusetti, F Dorigatti, H Hasson, A Danise, M Guffanti, A Lazzarin, A Rubinacci

Journal:

Year:

2005

Language:

english

File:

PDF, 95 KB

english, 2005

2

The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once daily

M-Y Tung, S Mandalia, M Bower, B Gazzard, M Nelson

Journal:

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

3

Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database

K Petoumenos, C Ringland, on behalf of the Australian HIV Observational Database

Journal:

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

4

Effects of antiretroviral treatment on blood–brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients

S Abdulle, L Hagberg, M Gisslén

Journal:

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

5

Gender difference in HIV-1 RNA viral loads

CA Donnelly, LM Bartley, AC Ghani, AM Le Fevre, GP Kwong, BJ Cowling, AI Van Sighem, F De Wolf, RA Rode, RM Anderson

Journal:

Year:

2005

Language:

english

File:

PDF, 110 KB

english, 2005

6

The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load

M Bickel, V Rickerts, C Stephan, V Jacobi, C Rottmann, B Dauer, A Carlebach, A Thalhammer, V Miller, S Staszweski

Journal:

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

7

Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: a 24-week randomized trial of treatment simplification using stavudine prolonged-release capsules

SD Portsmouth, J Osorio, K McCormick, BG Gazzard, GJ Moyle

Journal:

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

8

The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis

A Winston, J McAllister, J Amin, DA Cooper, A Carr

Journal:

Year:

2005

Language:

english

File:

PDF, 93 KB

english, 2005

9

Determinants of clinical progression in antiretroviral-naïve HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996–2002

F Bonnet, R Thiébaut, G Chêne, D Neau, J-L Pellegrin, P Mercié, J Beylot, F Dabis, R Salamon, P Morlat, for the Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA)

Journal:

Year:

2005

Language:

english

File:

PDF, 113 KB

english, 2005

10

Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London

AH Mohsen, S Murad, PJ Easterbrook

Journal:

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

11

Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD)

J Zhou, N Kumarasamy, on behalf of the TREAT Asia HIV Observational Database

Journal:

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005